Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Eye tracker probes whether depression pulls gaze toward One's own reflection

NCT ID NCT05464550

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers want to know whether people with depression spend more time looking at their own reflection after recalling a personal failure. The study uses an eye tracker to measure where participants look on a reflective black screen before and after a directed autobiographical recall. Thirty adults with depressive disorders take part. The goal is to understand how self-focused attention works in depression, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eye-tracking task with directed autobiographical recall
What this could lead to
If the link holds, this could sharpen how clinicians understand and measure self-focused attention in depression, possibly informing future psychological treatments.
What could go wrong
This is a small, early study of 30 people, so it cannot prove cause or effect. Eye-tracking results may not generalise, and the task may not capture real-world attention patterns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Dec 2021

Finished

Jun 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients with depressive disorders according to the Diagnostic and statistical Manual of Mental Disorders (DSM-V) criteria * Men or women, aged 18 to 60 * patients without mental impairment * patients without neurological impairment (epilepsy, encephalopathy, head trauma) * patients with a sufficient command of French * free patients, without guardianship or curators or subordination * patients benefiting from coverage by a social security scheme or benefiting from it through a third party in accordance with the French law on biomedical research * obtaining oral non-objection by the patient after clear and honest information about the study * Patient with normal or corrected vision without rigid contact lenses Exclusion Criteria: * patients with an intelligence quotient \< 70 * patients aged \< 18 years or \> 60 years * patients with mental impairment * patients with neurological impairment (epilepsy, encephalopathy, head trauma) * patients who do not speak French well enough * patients hospitalized under duress * patients without social security * Patient wearing rigid contact lenses

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Henri Laborit

    Poitiers, 86000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.